Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Use of Human Lung Tissue Models for Screening of Drugs against SARS-CoV-2 Infection.

Autor: McAuley AJ; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., Jansen van Vuren P; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., Mohammed MU; Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333031, India., Faheem; Department of Medicinal Chemistry, University of Utah, Salt Lake City, UT 84112, USA., Goldie S; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., Riddell S; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., Gödde NJ; The Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD 4075, Australia., Styles IK; Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Bruce MP; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., Chahal S; Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC 3000, Australia., Keating S; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., Blasdell KR; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., Tachedjian M; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., O'Brien CM; Manufacturing, Commonwealth Scientific and Industrial Research Organisation, Research Way, Clayton, VIC 3168, Australia.; Australian Regenerative Medicine Institute, Monash University, Clayton, VIC 3168, Australia., Singanallur NB; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia., Viana JN; Australian National Centre for the Public Awareness of Science, Australian National University, Canberra, ACT 2601, Australia.; Responsible Innovation Future Science Platform, Commonwealth Scientific and Industrial Research Organisation, Boggo Road, Dutton Park, QLD 4102, Australia., Vashi AV; Manufacturing, Commonwealth Scientific and Industrial Research Organisation, Research Way, Clayton, VIC 3168, Australia., Kirkpatrick CM; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., MacRaild CA; Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Shah RM; Department of Chemistry and Biochemistry, Swinburne University of Technology, Hawthorn, VIC 3122, Australia., Vincan E; Victorian Infectious Diseases Reference Laboratory, Melbourne, VIC 3000, Australia.; Department of Infectious Diseases, University of Melbourne, Melbourne, VIC 3000, Australia., Athan E; School of Medicine, Deakin University, Pigdons Road, Waurn Ponds, VIC 3216, Australia., Creek DJ; Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Trevaskis NL; Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC 3052, Australia., Murugesan S; Department of Pharmacy, Birla Institute of Technology and Science, Pilani 333031, India., Kumar A; Land & Water, Commonwealth Scientific and Industrial Research Organisation, Waite Campus, Urrbrae, SA 5064, Australia., Vasan SS; Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Research Organisation, Portarlington Road, Geelong, VIC 3220, Australia.; Department of Health, 189 Royal Street, East Perth, WA 6004, Australia.; Department of Health Sciences, University of York, York YO10 5DD, UK.

Publikováno v: Viruses [Viruses] 2022 Oct 31; Vol. 14 (11). Date of Electronic Publication: 2022 Oct 31.

A Chemical Screening Approach to Identify Novel Key Mediators of Erythroid Enucleation.

Autor: Wölwer CB; Cell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Pase LB; Cell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Pearson HB; Cell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Gödde NJ; Cell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia., Lackovic K; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Australia., Huang DC; The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Australia., Russell SM; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Immune Signaling Laboratory, Peter MacCallum Cancer Centre, Melbourne, Australia.; Centre for Micro-Photonics, Faculty of Engineering and Industrial Sciences, Swinburne University of Technology, Hawthorn, Australia., Humbert PO; Cell Cycle and Cancer Genetics, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australia.; Department of Pathology, University of Melbourne, Melbourne, Australia.; Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria, Australia.

Publikováno v: PloS one [PLoS One] 2015 Nov 16; Vol. 10 (11), pp. e0142655. Date of Electronic Publication: 2015 Nov 16 (Print Publication: 2015).

Mitotic spindle orientation: semaphorin-plexin signaling flags the way.

Autor: Humbert PO; Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3052, Australia; Department of Pathology, The University of Melbourne, Parkville, Victoria 3052, Australia; Department of Molecular Biology and Biochemistry, The University of Melbourne, Parkville, Victoria 3052, Australia. Electronic address: patrick.humbert@petermac.org., Gödde NJ; Cell Cycle and Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria 3052, Australia.

Publikováno v: Developmental cell [Dev Cell] 2015 May 04; Vol. 33 (3), pp. 243-4.

Differential coding potential of ADAM22 mRNAs.

Autor: Gödde NJ; Department of Surgery, University of Melbourne, Parkville 3050, Australia. n.godde@pgrad.unimelb.edu.au, D'Abaco GM, Paradiso L, Novak U

Publikováno v: Gene [Gene] 2007 Nov 15; Vol. 403 (1-2), pp. 80-8. Date of Electronic Publication: 2007 Aug 23.